Provided by Tiger Trade Technology Pte. Ltd.

Teva Pharmaceutical

35.88
-0.5650-1.55%
Volume:1.73M
Turnover:61.83M
Market Cap:41.79B
PE:59.79
High:36.12
Open:36.10
Low:35.62
Close:36.44
52wk High:38.37
52wk Low:18.14
Shares:1.17B
Float Shares:1.09B
Volume Ratio:0.90
T/O Rate:0.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6000
EPS(LYR):1.21
ROE:9.69%
ROA:5.13%
PB:5.39
PE(LYR):29.65

Loading ...

Mar 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 26, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 28, 2026

Major Issues Report

Form 8-K - Current report
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2025

Major Issues Report

Form 8-K - Current report